Prot #ABI-007-PANC-009: An Open-Label, Multicenter, Single-Arm, Phase 1/2 Study Of Metronomic 5-Fluorouracil In Combination With Nabpaclitaxel, Bevacizumab, Leucovorin, And Oxaliplatin In Patients With Metastatic Pancreatic Adenocarcinoma

Project: Research project

Project Details

StatusFinished
Effective start/end date8/10/168/10/19

Funding

  • INC Research, LLC (Prot #ABI-007-PANC-009)
  • Celgene Corporation (Prot #ABI-007-PANC-009)